The multiple K + channels are crucial for repolarization and configuration of the action potential in the neuronal and cardiac cells. In this study, we report the regulatory mechanisms of rapidly inactivating Shaker Kv1.4 channel transcript in the rat heart. Quantitative PCR analysis showed that stimulation with high concentration of KCI, or 
Introduction
The multiple K + channels are important for repolarization and configuration of action potential in neuronal and cardiac cells ( I ). Despite detailed biophysiological and pharmacological characterization of heterologously expressed channels, the exact physiological function and transcriptional regulation ofspecific K+ channel gene product in the mammalian heart have not been elucidated. In the rat heart, four distinct Shaker (Kvl.l, Kvl.2, KvI.4, and Kv1.5), 1 Shal (Kv4.2), and 1 Shab K+ channels (Kv2. 1) are reported to be expressed (2) .
They show extensive amino acid sequence identity with Shaker K+ channels over the putative membrane-spanning core region and most of these mammalian homologs, when expressed individually in Xenopus oocytes, produce noninactivating or very slowly inactivating currents. The exception in this subfamily is Kv 1.4, which elicits a rapidly inactivating A-type current in Xenopus oocytes (3) .
We have previously reported Northern blot hybridization and RNase protection analyses indicating that the transcript encoding for Kv1.5 is expressed in heart, skeletal muscle, and brain. The transcript is regulated in a tissue and developmentally specific manner (4) . In addition, we reported the isolation of a genomic clone where a cAMP responsive element was identified in the 5' noncoding region ofthe channel. Our results document that an elevation in intracellular cAMP increases the steady state levels of Kv 1.5 transcript in spontaneously beating neonatal rat atrial cells, suggesting that the expressional patterns of K+ channel genes are not static (5) . If a physiological K+ channel unit in the membrane is assembled with heterogenous K+ channel gene products, changes in delayed rectifier Kvl.5 gene expression may affect formation of K+ channel protein. In the first part of this study we focused on regulatory mechanisms for the gene expression of a rapidly inactivating A-type Kv1.4 channel, another important K+ channel in the Shaker subfamily, distinct in terms ofexpressed currents. Interestingly, its developmental pattern in the heart is quite distinct from that of delayed rectifier Kv1.5. It is possible that the Kv 1.4 transcript is regulated by intracellular calcium mobilization and protein kinase C (PKC).'
Cardiac hypertrophy is associated with changes in a wide range of intracellular signals, such as increased intracellular calcium, cAMP, inositol phosphates, and diacylglycerol concentrations (for review see reference 6) . Because the gene expressions of Kv 1.4 and Kv 1.5 channels could be modulated by these signals, and also because the plateau phase of action potential in hypertrophic myocardium is reported to be greatly prolonged (7) (8) (9) , we reasoned that cardiac hypertrophy would regulate the expressional patterns ofthese genes in the heart. In the second part of this study we demonstrate that the steady state levels of Kvl.4 and Kv1.5 gene expression are differentially regulated in response to cardiac hypertrophy. The hypertrophy-dependent differential regulation of Kv1.4 and Kvl.5 mRNAs in the heart raises the possibility that the formation of voltage-gated K+ channel protein on the membrane can be changed in either physiological or pathophysiological states.
Methods
Primary cultures. Primary culture of neonatal rat ventricular myocytes was prepared as described previously ( 10) . In brief, ventricles removed from neonatal Kbl: Wistar rats ( 1-3 d after birth) were dissociated by stirring gently with 0.25% trypsin solution for 5 min. After discarding the first extraction to remove red blood cells, the remaining tissues were further digested by stirring with the fresh enzyme. After 10 min, the cells in the supernatant were removed and placed into ice-cold DME with 20% FBS. This extraction procedure was repeated [7] [8] [9] [10] times. The combined cell suspensions were passed through 100-,Mm nylon mesh and centrifuged. The cell pellets, which consisted primarily of cardiomyocytes and nonmuscle cells, were resuspended in 20 ml of DME with 10% FBS. The cell suspensions were incubated for 90 min at 370C in 100-mm dishes, which allowed for selective attachment of nonmuscle cells to the dishes as described elsewhere ( ). The cardiomyocyteenriched suspensions were removed from the culture dishes and replaced with DME containing 10% FBS and 100MM ofthe DNA synthesis inhibitor, bromodeoxyuridine. The cardiomyocytes were seeded at densities of 3 x 106 cells per 100-mm dish. Each dispersion procedure yielded an average of 20 dishes from 40 neonatal rat ventricles, which were divided for the experiments. Each culture experiment was repeated with four separate samples obtained from four different preparations. The cells were incubated at 37"C under a humidified atmosphere of 95% air-5% CO2. After 48 h, the cells were rinsed with PBS, and the medium was replaced with serum-free DME containing 5.4 mM KCI, into which various chemicals were added to observe effects on K+ channel mRNA levels. In this experimental condition, the cultured cells were spontaneously beating, which was consistent with the observations in other studies ( 12, 13) .
To obtain nonmuscle cell-enriched fraction, the culture dishes containing attached nonmuscle cells were plated into an incubator and passaged 48 h later with 0.25% trypsin, as described elsewhere (1 1). The cells were plated in DME containing 10% FBS at a density of 2 X 104 cells in a 100-mm culture dish. After 5 d, the media were aspirated, and cells were washed with PBS and treated with guanidium isothiocyanate cesium chloride to obtain cellular RNA.
Quantitative reverse transcription (RT) and PCR assay. First strand cDNA was synthesized from total RNA isolated by guanidium isothiocyanate-cesium chloride centrifugation (14) with the Gene Amp RNA PCR kit from Perkin-Elmer Cetus Corp. (Norwalk, CT) with random hexamers as primers. In brief, total RNA samples were transcribed with random hexamers (2.5 MM), dNTPs (1 mM) 17, 20 , and 24 wk (n = 5, respectively) and age-matched male (n = 4, respectively), genetically normotensive control strains, were used in the study. Two-kidney, one-clip renovascular hypertensive rats (2K1C RHR) were produced in male Kbl: Wistar rats (4-wk-old) by placing a silver clip (0.2 mm) on the left renal artery and leaving the contralateral kidney untouched (14) . Sham-operated rats served as controls. In the experiment to examine developmental changes of K+ channels mRNA levels, male Crj: Sprague-Dawley rats were used. Animals were housed in a temperature-, humidity-, and light-controlled room, and a standard rat diet and water were provided ad lib. Systolic blood pressure and heart rate were measured once a week using the tail-cuffmethod, and body weight was checked. When systolic blood pressure reached a level greater than 160 mmHg within 2 wk after clipping, the rats were regarded as renovascular hypertensive rats. On the day of experiment, the rats were killed by decapitation. The heart was removed and the half of apex in the left ventricle was used for RNA preparation. Reversal of renovascular hypertension. 6 were divided into three groups. We reduced ti two procedures. The first group (n = 4) was tr enzyme inhibitor enalapril (Banyu Pharma The drug was given in distilled water by oral g twice daily for 4 wk. In the second group (n was removed under ether anesthesia. The ri received neither drug treatment nor nephrect( group is referred to as untreated RHR. They ' = 4) and 10 wk (n = 4) after clipping. In add control rats were also examined 6 wk (n = 4 sham-operation.
Reagents (Fig. 1 A) 4 for the indicated time (in hours). K+ Channel Gene Regulation in the Heart 1661 Results effect on the Kvl .4 transcript. As shown in Fig. 2 (Fig. 3 A) . The effects can be detected as early as 1 h after the addition of BAY-K 8644, and the response peaks at 3 to 5 h after stimulation. This is followed by a gradual decrease, reaching control levels by 24 h. Addition of the calcium-channel antagonist nifedipine before BAY-K 8644 completely inhibited the stimulation (Fig. 3 A) . Over the time course ofthe experiment, control cells did not show any change in steady state levels of the transcript. RT-PCR products of f3-actin were also consistently unchanged (Fig. 3 A) .
Since it is suggested that an increase in intracellular calcium concentration lowers the threshold of PKC activation (21 ), we examined the effect of phorbol esters that can pharmacologically alter PKC activity on Kvl.4 mRNA levels. As shown in Fig. 4 A, the levels of Kvl1.4 transcript in cardiomyocyteenriched culture cells are increased up to 3.5-fold by TPA, while those in nonmuscle cell-enriched culture were unaffected. The stimulatory effect can be detected 1 h after the addition ofTPA, and the response peaks at 3 to 5 h after stimulation. The stimulatory effect of TPA was completely blocked by the addition of H-7 (Fig. 4 A) . A phorbol ester that does not stimulate PKC, 4-a-phorbol, did not elicit any changes in Kv 1.4 mRNA levels (data not shown). As shown in Fig. 4 4 A. An increase in intracellular cAMP levels by dibutyryl cAMP ( 1 mM) did not influence the steady state levels of Kv 1.4 transcript in the cardiomyocyte-enriched culture cells (Fig. 3 C) . In addition, the stimulation with BAY-K 8644 or TPA did not induce any significant change in the Kvl.5 mRNA levels (Figs. 3 B and 4 
B).
Developmental changes of ventricular KvJ.S and Kv1.4 mRNA levels. Our previous study (4) and Swanson et al. ( 15) have shown that Kv 1.5 mRNA levels are developmentally regulated. As shown in Fig. 5 , Kvl .5 mRNA levels in ventricles are and Kv1.4 mRNA levels in the heart could be modified by these signals, and because it is known that the plateau phase of the action potential is greatly altered in hypertrophic ventricles (7-9), we attempted to examine the expression patterns of these genes in response to cardiac hypertrophy in two distinct models of SHR and two-kidney, one-clip renovascular hypertensive rats (2KIC RHR). Table I shows the hemodynamic data ofSHR and its genetic normotensive control, WKY. SHR are genetically hypertensive rat strains that have been studied widely and intensively in hypertension research (22) . The ventricular hypertrophy suggested by a significant increase in the ratio ofleft ventricular and body weight, as compared to that in age-matched WKY, was observed at 20 wk, which was confirmed by the increased amounts of ANF mRNA, generally accepted as one ofmarks ofventricular hypertrophy (6) . It is of interest to note that cardiac hypertrophy in SHR causes a dramatic reduction of Kvl.5 mRNA levels in ventricles (Fig. 6 ).
This reduction is evident as early as 17 wk: Suggestive ventricular hypertrophy judged by the ratio of ventricular and body weight is not yet apparent, but the process of hypertrophic change has begun on a biochemical level, as indicated by the increased ANF mRNA levels. The reduction of ventricular Kv1.5 mRNA in WKY at 24 wk is consistent with the normal developmental pattern described in Fig. 5 . On the other hand, Kv1.4 mRNA accumulations were remarkably increased in SHR at 20 and 24 wk, although the Kvl.4 mRNA levels in WKY at these weeks were decreased according to a normal developmental pattern. RT-PCR products ofB-actin appeared to be similar in these hypertensive rats (Fig. 6 ). This differential response of ventricular Kvl.5 and Kvl.4 transcripts was consistently observed in all experimental rats (see Table I for numbers of animals).
To confirm further the differential change of Kvl.5 and Kv 1.4 mRNAs and examine the effect of regression of cardiac hypertrophy on these changes, we employed the 2KlC RHR with more prominent ventricular hypertrophy. The clipped renal artery produces increased levels of plasma renin, aldosterone, and angiotensin II, resulting in the severe renovascular hypertension-induced hypertrophy ( 14) . The elevated level of blood pressure can be completely normalized by the removal of clipped kidney or treatment by angiotensin I converting enzyme (ACE) inhibitor, accompanied by the regression of cardiac hypertrophy. Table I shows the hemodynamic data and cardiac ANF mRNA levels in sham-operated controls and 2KIC RHR untreated for 6 or 10 wk after clipping, or treated with nephrectomy and enalapril (ACE inhibitor) for 4 wk after the 6-wk clipping. The presence of cardiac hypertrophy is suggested by the remarkably increased values of the ratio of left ventricular and body weight (twofold) and left ventricular ANF mRNA levels (eightfold), when compared to those in the sham-operated controls. Nephrectomy and treatment with enalapril for 4 wk completely normalized the ratio of ventricular and body weight and ventricular ANF mRNA levels. Fig. 6 shows the expression patterns of Kv 1.5 and Kv 1.4 mRNAs in the development (6 and 10 wk after clipping) and regression of cardiac hypertrophy. Similar to the results of SHR, Kvl.5 mRNA levels are dramatically repressed and Kvl.4 mRNA levels are remarkably augmented in the untreated 2KIC RHR. The differential changes of these mRNAs appears to be more apparent than those in SHR. Treatments with enalapril and nephrectomy reversed these changes to the normal steady state levels, together with the regression of hypertrophy. Similar results were observed consistently in all experimental rats (see Table I for numbers of animals).
Discussion
Understanding the expression mechanisms for K+ channel genes represents an informative initial step toward elucidating the function of specific K+ channel proteins. The anatomical distribution and pathological changes of the various types of voltage-sensitive K+ channels in the mammalian heart have been difficult to study, partly because of the paucity of high affinity ligands or pharmacological antagonists effective as specific probes in contrast to neurotransmitter-gated channels or sodium channels (23) . However, the successful cloning of a family of K+ channel cDNA has greatly facilitated the approach to this problem. The regression of ventricular hypertrophy was performed by antihypertensive treatments with enalapril or nephrectomy of the clipped kidney after the lateral renal artery had been clipped for 6 wk. Experiments were repeated with similar results in separate samples (see Table I for numbers of experimental rats), and representative results are shown.
In the first part of our experiments, we raised the possibility that the Kvl.4 (25, 27) . It has been assumed that late-responding genes may be regulated at the transcriptional level by the products of immediate early genes, many of which encode DNA-binding proteins (27, 28 (8, 9) , cat (7), and human (33) are greatly altered, typical changes being depression ofthe membrane voltage during the action potential plateau and prolongation ofthe plateau phase. Such alterations in the action potential were also recorded in hypertrophied ventricles of 2KlC RHR (7-14 wk after clipping) produced from Wistar rats (8) or in those of 16-wk-old SHR (9), the same experimental models as in the present study. The delayed rectifier K+ current is one ofimportant outward K+ currents involved in the configuration of cardiac action potential ( 1) . TenEick et al. have demonstrated that the prolonged duration is closely involved in a significant decrease in the time-dependent outward current (34) . Our observation that delayed rectifier Kv 1.5 expression is remarkably repressed could account for one of the important molecular mechanisms responsible for the prolonged duration of action potential recorded in hypertrophied ventricles. Compared to the role of delayed rectifier Kv 1.5 in hypertrophy, the effect of increased expression of rapidly inactivating Kv1.4 on the altered action potential remains to be determined. Such alterations in the repolarization time may be in part involved in the frequent occurrence of ventricular dysrhythmia in patients with hypertrophic hearts ( 33, 35 ) . Thus, since the voltage-sensitive Shaker K+ channel expressions could be changed from the steady state level in response to many signal transductions, it is likely that K+ conductance and action potential are readily altered in many pathological stages such as hypertrophy, ischemia, and heart failure. Our present study is the first to demonstrate such phenomena in the molecular level, and further investigation of K+ channel gene regulation in human diseased heart is now in progress.
